Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro

Veterinary Journal

Volumn 181, Issue 3, 2009, Pages 321-325

  Gu, Jian Hong ^a   Liu, Jun Dong ^b   Shen, Yan ^a   Liu, Zong Ping ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Jiangsu Animal Husbandry and Veterinary College   (China)

Author keywords

Calcium; Muscovy ducks; Osteoclasts; Osteoprotegerin; Phosphorus; RANKL

Indexed keywords

CALCIUM; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN FUNCTION;

ANIMALS; CALCIUM; CELLS, CULTURED; DUCKS; OSTEOCLASTS; OSTEOPROTEGERIN; PHOSPHORUS; RANK LIGAND;

CAIRINA MOSCHATA;

EID: 67349202449     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.03.006     Document Type: Article

References (28)

1. Aldridge S.E., Lennard T.W.J., Williams J.R., and Birch M.A. Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochemical and Biophysical Research Communications 335 (2005) 793-798
2. Blair J.M., Zheng Y., and Dunstan C.R. RANK ligand. International Journal of Biochemistry and Cell Biology 39 (2007) 1077-1081
3. Blair J.M., Zhou H., Seibel M.J., and Dunstan C.R. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nature Clinical Practice Oncology 3 (2006) 41-49
4. Boissy P., Destaing O., and Jurdic P. RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons. Biochemical and Biophysical Research Communications 288 (2001) 340-346
5. Bridgham J.T., and Johnson A.L. Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin. Biochemical and Biophysical Research Communications 307 (2003) 956-961
6. Burgess T.L., Qian Y., Kaufman S., Ring B.D., Van G., Capparelli C., Kelley M., Hsu H., Boyle W.J., Dunstan C.R., Hu S., and Lacey D.L. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. Journal of Cell Biology 145 (1999) 527-538
7. Chambers T.J., and Magnus C.L. Calcitonin alters behaviour of isolated osteoclasts. Journal of Pathology 136 (1982) 27-39
8. Cohen Jr. M.M. The new bone biology: pathologic, molecular, and clinical correlates. American Journal of Medical Genetics Part A 140 (2006) 2646-2706
9. Duong L.T., and Rodan G.A. Regulation of osteoclast formation and function. Reviews in Endocrine and Metabolic Disorders 2 (2001) 95-104
10. Horowitz M.C., Xi Y., Wilson K., and Kacena M.A. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine and Growth Factor Reviews 12 (2001) 9-18
11. Ito M., Amizuka N., Nakajima T., and Ozawa H. Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 25 (1999) 447-452
12. Kong Y.Y., and Penninger J.M. Molecular control of bone remodeling and osteoporosis. Experimental Gerontology 35 (2000) 947-956
13. Li B.B., Yu S.F., and Pang S.Z. Comparison of two methods of isolation and culture of osteoclasts and the dynamic observation of bone resorption. Journal of Peking University (Health Sciences) 37 (2005) 536-541 (in Chinese)
14. Lorget F., Kamel S., Mentaverri R., Wattel A., Naassila M., Maamer M., and Brazier M. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochemical and Biophysical Research Communications 268 (2000) 899-903
15. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schlöndorff J., Tempst P., Choi Y., and Blobel C.P. Evidence for a role of a tumor necrosis factor-alpha (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. Journal of Biological Chemistry 274 (1999) 13613-13618
16. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcified Tissue International 34 (1982) 285-290
17. Nakao A., Fukushima H., Kajiya H., Ozeki S., and Okabe K. RANKL-stimulated TNFα production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signalling pathways. Biochemical and Biophysical Research Communications 357 (2007) 945-950
18. Plotkin L.I., Manolagas S.C., and Bellido T. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs. Bone 39 (2006) 443-452
19. Sabokbar A., Kudo O., and Athanasou N.A. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. Journal of Orthopaedic Research 21 (2003) 73-80
20. Saintier D., Khanine V., Uzan B., Ea H.K., Vernejoul M.C.D., and Cohen-Solal M.E. Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. Journal of Steroid Biochemistry and Molecular Biology 99 (2006) 165-173
21. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Lüthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Amgen E.S.T. program, and Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
22. Suda T., Nakamura I., Jimi E., and Takahashi N. Regulation of osteoclast function. Journal of Bone Mineral Research 12 (1997) 869-879
23. Theoleyre S., Wittrant Y., Couillaud S., Vusio P., Berreur M., Dunstan C., Blanchard F., Rédini F., and Heymann D. Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor κB ligand and MAPK. Biochimica et Biophysica Acta 1644 (2004) 1-7
24. Theoleyre S., Wittrant Y., Tat S.K., Fortun Y., Redini F., and Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine and Growth Factor Reviews 15 (2004) 457-475
25. Wang H.F. An Atlas of Bone Cells and Cell Culture Techniques (2001), Shanghai Technology and Science Press, Shanghai, China pp. 55-69 (in Chinese)
26. Wittrant Y., Theoleyre S., Couillaud S., Dunstan C., Heymann D., and Rédini F. Regulation of osteoclast protease expression by RANKL. Biochemical and Biophysical Research Communications 310 (2003) 774-778
27. Wittrant Y., Theoleyre S., Couillaud S., Dunstan C., Heymann D., and Rédini F. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-κB ligand and osteoprotegerin biological activities. Experimental Cell Research 293 (2004) 292-301
28. Yao J., Qian C.Z., Zhang J., Zhang J., and Hou J.F. Isolation, culture and identification of osteoclasts from the chick embryo. Journal of Nanjing Agricultural University 28 (2005) 88-91